CELLDEX THERAPEUTICS INC NEW - COM (CLDX)

CUSIP: 15117B103

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class
Equity / COM
Total 13F shares
79,254,129
Share change
-6,105,810
Total reported value
$347,933,697
Put/Call ratio
70%
Price per share
$4.39
Number of holders
138
Value change
-$24,852,152
Number of buys
59
Number of sells
65

Quarterly Holders Quick Answers

What is CUSIP 15117B103?
CUSIP 15117B103 identifies CLDX - CELLDEX THERAPEUTICS INC NEW - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CELLDEX THERAPEUTICS INC NEW - COM (CLDX) as of Q2 2016

As of 30 Jun 2016, CELLDEX THERAPEUTICS INC NEW - COM (CLDX) was held by 138 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 79,254,129 shares. The largest 10 holders included FMR LLC, OppenheimerFunds, Inc., VANGUARD GROUP INC, FRANKLIN RESOURCES INC, COLUMBIA WANGER ASSET MANAGEMENT LLC, STATE STREET CORP, BlackRock Fund Advisors, DEUTSCHE BANK AG\, BlackRock Institutional Trust Company, N.A., and BOGLE INVESTMENT MANAGEMENT L P /DE/. This page lists 138 institutional shareholders reporting positions in this security for the Q2 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.